Anthem (NASDAQ:ANTX) Director Sells $212,766.02 in Stock

Key Points

• Director Robin Shane Readnour sold 35,402 shares of Anthem at an average price of $6.01, totaling $212,766.02. The sale reduced the director’s ownership by 5.89% to 565,592 shares.
• ANTX shares recently traded at $5.96, with a market capitalization of approximately $224.9 million. The company reported a quarterly loss of $0.18 per share, while its stock remains below its 12-month high of $7.19.
• Analyst sentiment is mixed, producing a consensus “Hold” rating and an average $9.00 price target. Institutional investors own 90.47% of the company, with several hedge funds establishing new positions during the first quarter.

Anthem, Inc. (NASDAQ:ANTX - Get Free Report) Director Robin Shane Readnour sold 35,402 shares of Anthem stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $6.01, for a total value of $212,766.02. Following the sale, the director directly owned 565,592 shares in the company, valued at $3,399,207.92. The trade was a 5.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link.

Anthem Stock Performance

Shares of ANTX stock traded down $0.01 during trading hours on Wednesday, hitting $5.96. The company had a trading volume of 266,091 shares, compared to its average volume of 711,744. Anthem, Inc. has a 12 month low of $1.00 and a 12 month high of $7.19. The firm's fifty day moving average is $5.08 and its 200 day moving average is $3.92. The firm has a market capitalization of $224.93 million, a price-to-earnings ratio of -5.57 and a beta of -0.99.

Anthem (NASDAQ:ANTX - Get Free Report) last posted its earnings results on Tuesday, August 11th. The company reported ($0.18) EPS for the quarter.

Analyst Upgrades and Downgrades

ANTX has been the topic of several recent analyst reports. Weiss Ratings restated a "sell (d-)" rating on shares of Anthem in a research note on Monday, July 6th. Guggenheim began coverage on shares of Anthem in a report on Monday, July 20th. They set a "buy" rating and a $9.00 price target for the company. Leerink Partners upgraded shares of Anthem from a "market perform" rating to an "outperform" rating and set a $9.00 price target on the stock in a research report on Thursday, May 14th. Finally, Wall Street Zen raised shares of Anthem from a "sell" rating to a "hold" rating in a research note on Sunday, June 14th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $9.00.

Hedge Funds Weigh In On Anthem

A number of institutional investors and hedge funds have recently bought and sold shares of ANTX. Vivo Capital LLC acquired a new stake in shares of Anthem in the first quarter valued at $10,785,000. Commodore Capital LP acquired a new position in Anthem during the 1st quarter worth about $7,981,000. Spruce Street Capital LP bought a new stake in Anthem during the 1st quarter worth about $5,576,000. Ally Bridge Group NY LLC bought a new stake in Anthem during the 1st quarter worth about $1,800,000. Finally, Seven Fleet Capital Management LP acquired a new stake in Anthem in the 1st quarter valued at about $683,000. Institutional investors and hedge funds own 90.47% of the company's stock.

Anthem Company Profile

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source